YBX1 and neoplasm: In this study, we demonstrate that pharmacological inhibition of LDHA using FX11 effectively impairs tumor growth and metastatic progression in PTC models, supporting LDHA as a potential therapeutic target within the SOX12-YBX1-LDHA signaling axis.